NDLI: Role of cyclophilin a during oncogenesis.

Please wait, while we are loading the content...

Anthraquinones from the roots of Knoxia valerianoides inhibit the formation of advanced glycation end products and rat lens aldose reductase in vitro.

Bee venom protects hepatocytes from tumor necrosis factor-alpha and actinomycin D.

Pharmacokinetics, tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats.

Bioactive metabolites from the sponge-derived fungus Aspergillus versicolor.

Inhibitory activity of diacylglycerol acyltransferase by glabrol isolated from the roots of licorice.

The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo.

Evaluation of plasma carcinogenic markers in rat hepatic tumors models induced by rat hepatoma N1-S1 cells and benzo[a]pyrene.

ATP induced microglial cell migration through non-transcriptional activation of matrix metalloproteinase-9.

Enantioselective pharmacokinetics of sibutramine in rat.

LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.

Interferon-gamma enhances the apoptosis of macrophages under trophic stress through activation of p53 and the JAK1 pathway.

Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride.

Increases in serotonergic neuronal activity following intracerebroventricular administration of AF64A in rats.

Assessment of the anti-angiogenic, anti-inflammatory and antinociceptive properties of ethyl vanillin.

Determination of pipecolic acid following trimethylsilyl and trifluoroacyl derivatisation on plasma filter paper by stable isotope GC-MS for peroxisomal disorders.

Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice.

Year: 2010 Volume: 33 Issue: 1

Year: 2009 Volume: 32

Year: 2008 Volume: 31

Year: 2004 Volume: 27

Year: 2002 Volume: 25

Year: 1997 Volume: 20

Role of cyclophilin a during oncogenesis.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Lee, Jinhwa
Description	Author Affiliation: Lee J ( Department of Clinical Laboratory Science, Division of Health Science, Dongseo University, Busan 617-716, Korea. jinhwa2000@gdsu.dongseo.ac.kr)
Abstract	Cyclophilins (Cyps) are ubiquitously expressed proteins that are evolutionarily conserved. CypA is the most abundant among the Cyps and is expressed in the cytosol. With its chaperone and PPIase activities, CypA contributes to the maintenance of correct conformation of nascent or denatured proteins and also provides protection against environmental insults. Also, its expression is induced in response to a wide variety of stressors including cancer. Upregulation of CypA in small cell lung cancer, pancreatic cancer, breast cancer, colorectal cancer, squamous cell carcinoma and melanoma has been reported. In some cancers a correlation between CypA overexpression and malignant transformation has been established. While molecular partners of CypA that promote cancer development are yet to be discovered, various mechanisms have been proposed to account for the cytoprotective functions of CypA during cancer development. CypA may promote the survival of cells under the stressful condition of cancer. CypA may well be essential for maintaining the conformation of oncogenic proteins, signalling proteins for cell proliferation, antiapoptotic components, transcription factors, or cell motility regulatory proteins. Antioxidant effects of CypA, which have been suggested by some researchers, may also become critical to reactive oxygen species (ROS) creating an oncogenetic environment. Developing new CypA inhibitors for therapeutics has been surmised from the cytoprotective functions of CypA and its overexpression in many cancer types. Therefore, CypA can be further investigated as a useful tool for early diagnosis, treatment and prevention of human cancers.
File Format	HTM / HTML
ISSN	02536269
Issue Number	2
Volume Number	33
e-ISSN	19763786
Journal	Archives of Pharmacal Research
Language	English
Publisher	Springer
Publisher Date	2010-02-01
Publisher Place	Korea (South)
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Pharmacology Cyclophilin A Physiology Neoplasms Drug Therapy Cell Survival Antagonists & Inhibitors Genetics Drug Delivery Systems Humans Metabolism Stress, Physiological Up-regulation Journal Article Research Support, Non-u.s. Gov't Review
Content Type	Text
Resource Type	Article
Subject	Organic Chemistry Drug Discovery Molecular Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.

Catabolic metabolism during cancer EMT.

Modulation of oxidative stress as an anticancer strategy.

Integrins as therapeutic targets: lessons and opportunities.

Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors.

Signal transducer and activator of transcription 3 inhibitors: a patent review.

Histone lysine demethylases as targets for anticancer therapy.

The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review.

The double-edged sword of AMPK signaling in cancer and its therapeutic implications.

Role of cyclophilin a during oncogenesis.

Similar Documents

Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.

Catabolic metabolism during cancer EMT.

Modulation of oxidative stress as an anticancer strategy.

Integrins as therapeutic targets: lessons and opportunities.

Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors.

Signal transducer and activator of transcription 3 inhibitors: a patent review.

Histone lysine demethylases as targets for anticancer therapy.

The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review.

The double-edged sword of AMPK signaling in cancer and its therapeutic implications.

Role of cyclophilin a during oncogenesis.